Rare diseases
Investigational molecules
Locations
Back to Ireland159 clinical trials in Cork, Ireland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Enzalutamide and Drug Combination for High-Risk Localized Prostate Cancer Patients
IrelandStudy on Tralokinumab and Topical Corticosteroids for Children and Infants with Moderate-to-Severe Atopic Dermatitis
IrelandStudy of lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa
IrelandStudy of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy
IrelandStudy Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments
IrelandStudy on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery
IrelandStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
IrelandStudy on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment
IrelandStudy on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions
IrelandStudy of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
IrelandStudy on the Effectiveness of Modified Vaccinia Ankara Vaccine in Preventing Mpox Infection in Adults
IrelandStudy of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer
IrelandThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on lung cancer treatments, including innovative therapies for non-small cell lung cancer and testing new drug combinations. Studies evaluating treatments for breast cancer, particularly in hormone receptor-positive and HER2-negative variants.
Multiple trials exploring combination therapies and novel treatment approaches for various cancer types.
Research initiatives examining treatments for chronic lymphocytic leukemia and lymphomas. Studies evaluating new therapeutic approaches for myelodysplastic syndromes, focusing on reducing transfusion dependency.
Innovative approaches combining multiple therapeutic agents to improve patient outcomes.
Clinical studies investigating treatments for Primary Sjögren's Disease and atopic dermatitis. Research on novel therapeutic approaches for inflammatory conditions and immune system disorders.
Focus on developing targeted therapies to improve patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
